Chamber Cardio Secures $60M to Shift Heart Care from Volume to Value

WASHINGTON, Feb. 4, 2026 – Health technology firm Chamber Cardio announced today it has closed a $60 million Series A funding round to accelerate its mission of transforming cardiology care in the United States. The investment, led by the prominent healthcare venture capital firm Frist Cressey Ventures, signals a major push to move one of medicine's most expensive specialties away from the traditional fee-for-service model and toward a system that pays for better patient outcomes.

The funding will fuel Chamber's national expansion, allowing it to forge new partnerships with health plans and cardiology practices while scaling its technology and clinical support teams. The round saw participation from a formidable syndicate of investors, including General Catalyst, Optum Ventures, and AlleyCorp, underscoring growing confidence in value-based care as the future for managing chronic, high-cost conditions.

Fixing a Fragmented System

Cardiovascular disease remains the single largest driver of healthcare costs and mortality in the U.S., with annual expenditures soaring past $400 billion. For decades, the system for treating heart disease has been largely reactive and fragmented. Patients see specialists for procedures and office visits, but care coordination often falters in between, leading to missed follow-ups, delayed interventions, and preventable hospitalizations that drive up costs for everyone.

Chamber aims to rebuild this system from the ground up by providing the infrastructure for value-based care—a model that incentivizes keeping patients healthy rather than simply performing more procedures.

"Cardiovascular disease is the largest driver of U.S. healthcare spend, yet care delivery remains fragmented and fee-for-service–driven," said Senator Bill Frist, M.D., Co-Founder and Managing Partner at Frist Cressey Ventures and a nationally recognized heart and lung transplant surgeon. "The Chamber platform brings value-based care to cardiology, delivering better outcomes and improved quality of life for patients and their families."

By partnering with both payers and cardiology practices, Chamber provides the tools and support necessary for long-term disease management. This approach directly addresses the gaps where patients are most vulnerable—the periods between appointments—by enabling continuous oversight and proactive intervention.

The Money Follows the Value

The $60 million investment is a significant validation of Chamber's approach and reflects a broader trend in healthcare investment. Venture capital firms are increasingly directing capital towards companies that can bend the healthcare cost curve, particularly in complex specialties that have been slow to adopt new payment models. While value-based care has gained a strong foothold in primary care, its application in cardiology has lagged, creating a substantial market opportunity.

Investors like Frist Cressey Ventures, with its deep roots in transforming care delivery, and General Catalyst, with its "Health Assurance" thesis focused on proactive and affordable care, see Chamber as a pivotal player in this transition. The inclusion of Optum Ventures, the venture arm of healthcare giant UnitedHealth Group, further signals strong payer interest in solutions that provide clearer visibility into costs and performance while improving patient health. This strategic backing provides Chamber not only with capital but also with deep industry expertise and potential pathways to broader market adoption.

The funding round also included participation from existing investors AlleyCorp, American Family Ventures, and Company Ventures, with new strategic investments from Healthworx Ventures and Black Opal Ventures, alongside debt financing from HSBC Innovation Banking. This diverse group of backers highlights a shared belief that the financial incentives in healthcare must align with patient well-being.

The AI Heartbeat in the Clinical Workflow

At the core of Chamber's model is a cardiology-focused data and intelligence platform designed to empower, not overwhelm, clinicians. The company's technology integrates what it calls "workflow-native AI" directly into a physician's existing processes. This isn't about adding another screen or a separate login; it's about embedding intelligent insights where they are most useful.

"Cardiovascular care generates enormous amounts of data, but clinicians don't need more data but rather a clearer signal," said Sameer Sheth, M.D., Co-Founder, President & CMO of Chamber.

The platform sifts through vast amounts of clinical data to identify high-risk patients who need immediate attention, flag gaps in guideline-directed medical therapy, and automate tasks like chart review that consume valuable clinician time. By providing a clearer signal, the technology enables cardiology teams to shift from a reactive to a proactive stance, intervening before a patient's condition deteriorates and requires a costly hospital visit. This focus on intelligent automation and clinical decision support is critical for making value-based models scalable and effective.

A New Partnership Model for Physicians

Perhaps one of the most compelling aspects of Chamber's strategy is its business model, which is designed to remove the barriers that have kept many independent cardiology practices from embracing value-based care. Instead of acquiring practices, Chamber partners with them, allowing physicians to maintain their autonomy.

The company provides its technology platform and operational support—including care teams and administrative assistance—at no cost to the practice. Critically, Chamber assumes the downside financial risk associated with value-based contracts. This means that if patient care costs exceed a set benchmark, Chamber, not the cardiology practice, absorbs the loss. This risk-sharing arrangement provides a powerful incentive for practices to join its network, as it allows them to benefit from the potential upside of value-based care without shouldering its inherent financial risks.

"Chamber is focused on building the infrastructure that helps cardiologists succeed in value-based care, supports more predictable performance for health plans, and ultimately delivers a better experience for patients with heart disease," said George Aloth, Co-Founder and CEO of Chamber.

Currently operating in seven states with a network of more than 500 cardiologists, the company is already demonstrating the viability of its model. The new infusion of capital will enable Chamber to expand its footprint nationwide, bringing its unique combination of technology, operational support, and risk-sharing to more cardiologists and the millions of patients they serve. As the healthcare industry continues its slow but steady march toward a system that rewards value, companies like Chamber are building the essential bridges to get there.